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Abstract
Background: FUS (TLS) and EWS (EWSR1) belong to the FET-protein family of RNA and DNA binding proteins. FUS
and EWS are structurally and functionally related and participate in transcriptional regulation and RNA processing.
FUS and EWS are identified in translocation generated cancer fusion proteins and involved in the human
neurological diseases amyotrophic lateral sclerosis and fronto-temporal lobar degeneration.
Results: To determine the gene regulatory functions of FUS and EWS at the level of chromatin, we have performed
chromatin immunoprecipitation followed by next generation sequencing (ChIP-seq). Our results show that FUS and
EWS bind to a subset of actively transcribed genes, that binding often is downstream the poly(A)-signal, and that
binding overlaps with RNA polymerase II. Functional examinations of selected target genes identified that FUS and
EWS can regulate gene expression at different levels. Gene Ontology analyses showed that FUS and EWS target
genes preferentially encode proteins involved in regulatory processes at the RNA level.
Conclusions: The presented results yield new insights into gene interactions of EWS and FUS and have identified a
set of FUS and EWS target genes involved in pathways at the RNA regulatory level with potential to mediate
normal and disease-associated functions of the FUS and EWS proteins.
Keywords: Transcriptional-regulation, Transcription-factors, RNA-processing, ChIP-sequencing, RNA-binding,
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Background
The FET-protein family comprises FUS (fused in sarcoma,
and also abbreviated TLS (translocated in liposarcoma)),
EWS (Ewing sarcoma breakpoint region 1, and also abbre-
viated EWSR1) and TAF15 (TATA box binding protein
associated factor 68 kDa) [1]. The FET-proteins are impli-
cated in cancer and originally identified as N-terminal
partners of different fusion oncoproteins [2–4]. FET-pro-
teins are also involved in neurological diseases with
FUS and TAF15 mutations identified in familial amyo-
trophic lateral sclerosis (ALS) [5–8], frontotemporal
lobar degeneration (FTLD) [9] and essential tremor dis-
orders [10].
FET-proteins are expressed in most human tissues and
cell types [11]. The FET-proteins are composed of sev-
eral conserved domains: SYGQ-rich N-terminal domain,
G-rich domain, RNA-binding domain (RRM), Zn-finger,
and C-terminal RGG-rich domain [12]. The N-terminal
region of FET-proteins has a transcriptional trans-
activating function and is involved in homo and hetero
dimerization [2, 13]. The C-terminal region is involved
in subcellular localization and constitutes a hot spot for
mutations associated with ALS and FTLD [11, 14–17].
FET-proteins shuttle between the cytoplasm and the nu-
cleus and have a C-terminal nuclear localization signal
[18, 19]. Cellular stress, as well as FUS and TAF15 muta-
tions present in ALS and FTLD, results in cytoplasmic
aggregation, appearing as immune reactive inclusion
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bodies in cultured cells and brain tissue. The inclusion
body formation is concomitant with less nuclear FUS
and TAF15 content [7, 8, 11, 13, 20]. The central and C-
terminal protein regions including the RRM, Zn-finger
and RGG-rich domains are implicated in RNA- and
DNA-binding [18, 21–24]. FET-protein RNA target identi-
fication showed binding to thousands of RNA species and
FET-proteins are functionally involved in transcriptional
regulation, mRNA splicing and polyadenylation, RNA
transport, RNA translation and microRNA (miRNA) pro-
cessing [25–27]. FET-proteins associate with a number of
factors involved in transcription and RNA processing,
such as RNA Polymerase II (RNAPII), the basal transcrip-
tional regulatory complex Transcription Factor IID
(TFIID), and splice and polyadenylation factors [1, 3, 18,
28–32]. Moreover, FET-proteins are present in the Drosha
miRNA processing complex [33, 34]. FUS and EWS have
also been described playing a role in DNA repair. FUS and
EWS deficient mice and zebra fish show defects in DNA
pairing and DNA repair [35–38] and the FET-proteins are
able to pair homologous DNA in vitro [39–41]. The pleio-
tropic functions of EWS and FUS are further illustrated by
the role of FUS in DNA damage responses [42]. FUS is
rapidly recruited to sites of double strand breaks in a
poly(ADP-ribose) polymerase dependent manner and FUS
depletion diminishes double strand break repair through
both homologous recombination and non-homologous
end-joining [42]. Furthermore, in response to DNA dam-
age, FUS binds to a non-coding RNA transcribed up-
stream of the cyclin D1 (CCND1) gene, which leads to the
inhibition of the histone acetyltransferase activities of
CREB-binding and p300 proteins, thereby repressing
CCND1 transcription [43]. RNA mediated recruitment of
FUS to promoter regions goes beyond mechanisms dir-
ectly related to DNA repair, and i.e. it was shown that in
cortical neurons FUS binds the antisense RNA strand at
the promoter region for a large set of genes and this re-
sults in transcriptional suppression of the coding strand
[44]. Other studies have shown transcriptional regulation
by FUS through promoter association such as involvement
in the regulation of RNAPII C-terminal domain Ser2
phosphorylation and accordingly RNAPII accumulation at
transcriptional start sites [24, 27]. This is functional linked
with downstream poly(A)-signal selection in a process
also dependent on FUS recruitment to the nascent
RNA [27, 31]. FUS was also shown to activate tran-
scription of genes related to oxidative stress defense
through promoter binding [45].
Considering the fundamental roles the FET-proteins
seem to play in normal cellular functions as well as in
different types of human diseases, it will be important to
elucidate the different mechanisms underlying the
function of these proteins. In this study we have per-
formed chromatin immunoprecipitation followed by
next generation sequencing (ChIP-seq) to identify poten-
tial binding sites of FUS and EWS at the chromatin
level. The results show that FUS and EWS bind down-
stream the poly(A)-signal in a subset of transcribed
genes, that target genes are enriched for functions re-
lated to various aspects of RNA regulation, and that, for
at least some of these genes, FUS and EWS have RNA
processing functions.
Results
Identification of FUS and EWS genome-wide DNA binding
sites
A hallmark of the FET-proteins is their ability to bind
nucleic acids including RNAs as well as single and
double stranded DNA [1, 12, 40, 41, 46, 47]. To identify
target genes for FUS and EWS we conducted ChIP-seq
analysis using human HEK-293 cells. We selected HEK-
293 cells since genomics and RNomics studies at the
time of our experimentation have used this genetic back-
ground to dissect regulatory functions of FUS and EWS,
thereby allowing comparative analyses. The selected FUS
and EWS monoclonal antibodies precipitated the ex-
pected proteins in cross-linked cell samples without any
detectable cross-reactivity. Following ChIP, the eluted
DNA fragments were subjected to Next Generation Se-
quencing (NGS) using the Illumina Hiseq 2000 platform.
An equivalent amount of input DNA was used for NGS
as a negative control and acetylated lysine 9 of histone
H3 (Ac-H3K9) was included as a positive control for ac-
tively transcribed genes. 107 sequence reads were ex-
tracted for each sample. The obtained raw sequence
reads were aligned to the human reference genome
(hg19) using Burrows-Wheeler Aligner [48]. For the
three ChIP samples, over 94 % of the sequence reads
were mapped to the reference genome (Fig. 1a). Aligned
sequence reads were further processed with MACS
1.4.0rc2 for peaks calling [49]. A significant peak was de-
fined using the criteria of a threshold ≥ 9 reads and p-
value ≤ 10−8 [50]. A total of 52 and 133 enrichment
peaks were significant for FUS and EWS, respectively,
and of these 41 FUS peaks and 103 EWS peaks were po-
sitioned inside or proximate (within a distance of 10 kb)
annotated genes (Additional files 1 and 2). We in the fol-
lowing focused on such peaks and characterized the dis-
tribution over target genes for the EWS and FUS peaks.
We reasoned that if a peak is positioned within or in
proximity of several genes, each of these genes should
be encountered potential target genes (also abbreviated
hits in the following). Using this approach, 134, 241, and
15115 genes were scored positive for FUS, EWS and Ac-
H3K9, respectively (Table 1 and Additional file 3). It
should be noted that since it is the distribution of ChIP
peaks per annotated gene present in UCSC, each ChIP
peak can results in multiple hits. Therefore, the
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numerical sum of the presented hits is accordingly not
equal to the number of peaks. A more detailed analysis
of the position of peaks revealed that a large proportion
of FUS (64 % (32 peaks)) and EWS (54 % (62 peaks))
peaks are located downstream the poly(A)-signal in tar-
get genes (Figure 1b and Table 1). The remaining enrich-
ment peaks for FUS and EWS were localized in the
upstream region (16 % and 20 %, respectively), inside in-
trons (13 % and 22 %, respectively) and within exons
(7 % and 5 %, respectively). We note that Ac-H3K9
peaks more often localized upstream of genes and in in-
trons and exons, whereas only a smaller number (14 %)
were assigned to localize downstream the poly(A)-signal
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Fig. 1 ChIP-seq profile of FUS and EWS binding sites in the human genome. a Total number of ChIP-seq reads and the ChIP-seq reads mapped
to the human genome for NGS sequenced samples. b Distribution in a gene based model of FUS, EWS, and Ac-H3K9 peaks in or nearby (within
distance of 10 kb) genes. Upstream region (Up, red) is defined as until 10 kb upstream of annotated gene transcriptional start sites, downstream
region (Down, blue) is defined as until 10 kb downstream of annotated gene poly(A)-signals, upstream + downstream (Up + Down, black)
specifies a chromosomal localization in where a peak is until 10 kb upstream for one gene but at the same time downstream of a neighboring gene,
exon (orange), intron (yellow), and exon and intron (exon is intron of another gene, green). The location is defined accordingly to the summit of a
given peak. c Position binding profile of FUS, EWS, and Ac-H3K9 based on a transcript based model in where each annotated transcript with a
FUS, EWS, or Ac-H3K9 peak, the peak is localized accordingly to the gene model illustrated in the upper left corner including the features
upstream (1–100), exon/intron (100–200), and downstream (200–300), and each feature further subdivided in smaller segments. The y-axis
represents the number of times (hits) each ChIP-seq peaks map to annotated UCSC gene transcripts at the given segment position in the
feature. Since multiple annotated transcripts often appear from one gene due to alternative splicing and promoter usage each ChIP-seq peak
can generate several hits. The location is defined accordingly to the summit of the given ChIP-seq peaks
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To identify the pathways to which FUS and EWS tar-
get genes belongs we performed a gene ontology (GO)
and Kyoto encyclopedia of genes and genomes (KEGG)
pathways analysis using the software ChIP-Enrich specif-
ically developed for gene set enrichment testing of ChIP-
seq results [51]. For these analyses we used a cut-off
FDR < 0.01. The most significant results are presented in
Table 2 and the complete output in Additional file 4.
ChIP-Enrich analysis revealed that for both FUS and
EWS the most enriched KEGG pathway is Ribosome
(p-values 5.79E-06 and 2.32E-07 for FUS and EWS, re-
spectively) (Table 2 and Additional file 4). The most
enriched GO Biological Process for both FUS and EWS
is Translational Elongation (p-values 1.27E-08 and
7.86E-13 for FUS and EWS, respectively). Additionally,
a prominent enrichment of regulatory processes at the
Table 2 ChIP-Enrich analysis of FUS and EWS ChIP-seq peaks
FUS ChIP-seq gene set enrichment analysis (FDR value < 0.01)
GO/KEGG ID GO/KEGG category Gene Set Description P value FDR
GO:0006414 Gene Ontology Biological Process translational elongation 1.27E-08 5.13E-05
GO:2000602 Gene Ontology Biological Process regulation of interphase of mitotic cell cycle 2.64E-07 5.34E-04
GO:0006415 Gene Ontology Biological Process translational termination 2.55E-06 0.0027
GO:0007346 Gene Ontology Biological Process regulation of mitotic cell cycle 2.67E-06 0.0027
GO:0006614 Gene Ontology Biological Process SRP-dependent cotranslational protein targeting to membrane 6.51E-06 0.00404
GO:0030530 Gene Ontology Cellular Component heterogeneous nuclear ribonucleoprotein complex 7.58E-08 3.74E-05
GO:0022626 Gene Ontology Cellular Component cytosolic ribosome 1.56E-06 3.85E-04
GO:0030529 Gene Ontology Cellular Component ribonucleoprotein complex 2.20E-05 0.00347
GO:0044391 Gene Ontology Cellular Component ribosomal subunit 2.81E-05 0.00347
GO:0022625 Gene Ontology Cellular Component cytosolic large ribosomal subunit 3.54E-05 0.00349
GO:0043566 Gene Ontology Molecular Function structure-specific DNA binding 8.88E-06 0.0077
path:hsa03010 KEGG Pathway Ribosome 5.79E-06 0.00108
EWS ChIP-seq gene set enrichment analysis (FDR value < 0.01)
GO/ KEGG ID GO/KEGG category Gene Set Description P value FDR
GO:0006414 Gene Ontology Biological Process translational elongation 7.86E-13 3.18E-09
GO:0006613 Gene Ontology Biological Process cotranslational protein targeting to membrane 1.58E-12 3.19E-09
GO:0006415 Gene Ontology Biological Process translational termination 4.60E-11 6.20E-08
GO:0006614 Gene Ontology Biological Process SRP-dependent cotranslational protein targeting to membrane 4.17E-10 3.91E-07
GO:0045047 Gene Ontology Biological Process protein targeting to ER 4.83E-10 3.91E-07
GO:0022626 Gene Ontology Cellular Component cytosolic ribosome 1.92E-11 9.49E-09
GO:0044391 Gene Ontology Cellular Component ribosomal subunit 4.70E-09 8.13E-07
GO:0030530 Gene Ontology Cellular Component heterogeneous nuclear ribonucleoprotein complex 4.95E-09 8.13E-07
GO:0030529 Gene Ontology Cellular Component ribonucleoprotein complex 1.67E-07 2.06E-05
GO:0005730 Gene Ontology Cellular Component nucleolus 2.95E-07 2.69E-05
GO:0003735 Gene Ontology Molecular Function structural constituent of ribosome 5.34E-08 2.70E-05
path:hsa03010 KEGG Pathway Ribosome 2.32E-07 4.33E-05
The presented ChIP-Enrich results represents for FUS the 5 most significant GO signatures for Biological Process and for Cellular Component, as well as the single
present GO signature for Molecular Function and KEGG pathway. For comparison the same set-up for ChIP-Enrich results were presented for EWS. The entire
ChIP-Enrich analyze list is included in Additional file 4
Table 1 Gene distribution of FUS, EWS and Ac-H3K9 ChIP-seq peaks in a gene based model
Protein All Exon Intron Exon + Intron Upstream Downstream Upstream + Downstream
FUS 134 9 17 1 21 86 0
EWS 241 11 52 2 47 129 0
Ac-H3K9 15115 2510 5911 804 3073 2164 653
Gene distributions were subdivided into six groups: exon, intron, exon + intron (exon is intron sequence in another gene), upstream (10 kb distance), downstream
(10 kb distance), and upstream + downstream. The latter specifies a chromosomal localization in where a peak is until 10 kb upstream for one gene but at the
same time downstream of a neighboring gene
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RNA level was observed within the GO Cellular Com-
ponent for FUS. The 5 most significant enriched gene
sets were heterogeneous nuclear ribonucleoprotein
complex, cytosolic ribosome, ribonucleoprotein com-
plex, ribosomal subunit, and cytosolic large ribosomal
subunit (Table 2 and Additional file 4). Four of these
five gene sets were also among the five most significant
EWS GO Cellular Component gene sets (Table 2 and
Additional file 4). Inspection of the entire FUS and
EWS ChIP-Enrich analysis revealed existence of many
additional GO enriched gene sets involved in regulatory
processes at the RNA level (Additional file 4).
To illustrate by an alternative approach the position of
FUS and EWS ChIP-seq peaks we next used a transcript
based model in which each annotated transcript was an-
alyzed for the presence of FUS, EWS, and Ac-H3K9
peaks within or in close distance to the transcript (up to
10 kb). The location of such peaks was mapped relative
to a standard gene model consisting of four genetic fea-
tures: upstream (before first exon), exon and intron, as
well as downstream representing a location after the
poly(A)-signal (Fig. 1c). Each of these features was sub-
divided into 100 segments for more precise mapping. As
shown in Figure 1c, FUS and EWS preferentially bind
the feature downstream of the poly(A)-signal. It should
again be noted that, since it is the distribution of ChIP
peaks per annotated gene transcript present in UCSC,
each ChIP peak can result in multiple hits. Fig 1c also il-
lustrates that Ac-H3K9 ChIP peaks, if designated to the
upstream feature mostly correspond to the 3’ end of this
feature, and if ChIP-peaks are designated to exons and
introns feature, the peaks mostly correspond to the 5’
end of this feature. This is in accordance with Ac-H3K9
being a mark for transcriptional start sites. Examples of
FUS, EWS, and Ac-H3K9 enrichment peaks are shown
for the ACPT and C19orf48 gene complex (with p values
scored number 7 of the 103 peaks and 16 of the 41
peaks for EWS and FUS, respectively), RCC1 and
SNHG3 gene complex (with p values scored number 5
of the 103 peaks and 3 of the 41 peaks for EWS and
FUS, respectively), and HNRNPK gene (with p values
scored number 34 of the 103 peaks and 26 of the 41
peaks for EWS and FUS, respectively) (Fig. 2a-c). The
read number is shown at the left axis of each figure. The
scale difference for the Ac-H3K9 ChIP-seq enrichment
(upper left) should be noted. The transcripts from UCSC
hg19 genomic database are shown at the bottom. ChIP-
seq results were validated by repeated ChIP experiments
and analysis of representative genomic regions by quan-
titative PCR (qPCR) (Additional file 5).
FUS and EWS bind actively transcribed genes
Cross comparison of the identified target genes for FUS
and Ac-H3K9 showed that out of 134 genes with FUS
binding assigned, 122 were also enriched for Ac-H3K9,
indicating that most FUS target genes are actively tran-
scribed (Fig. 3a and b and Additional file 6). The same
was observed for EWS target genes, since out of 241
genes with EWS binding assigned, 199 were also
enriched for Ac-H3K9 (Fig. 3 and Additional file 6). Fur-
ther analysis of FUS and EWS ChIP-seq peaks revealed
that a large proportion of target genes were bound by
both FUS and EWS (Fig. 3 and Additional file 6). To val-
idate if FUS and EWS target genes represented actively
transcribed genes, we compared our ChIP-seq datasets
with mRNA expression analyses previously conducted in
HEK-293 cells [17]. We analyzed the expression profile
of targeted genes in two DNA microarray datasets (ex-
pression arrays A664_04 and A664_06 [17]). Among the
48,803 probe sets representing 17,202 unique genes in
the Illumina GPL6884 microarray, we identified 35
probe sets representing ChIP-seq target genes for FUS
and Ac-H3K9, 135 probe sets for EWS and Ac-H3K9,
and 58 probe sets for FUS, EWS, and Ac-H3K9
(Additional file 7). In addition, we identified 2, 31 or 3
probe sets representing the ChIP-seq targeted genes with
binding of FUS, EWS, or both, respectively, in the ab-
sence of Ac-H3K9 (Additional file 7). We note that the
transcripts presented on the microarray are enriched for
mRNA with protein coding potential and thereby most
ncRNAs are excluded from our analyses. By comparing
the relative expression level of FUS, EWS, or FUS and
EWS target genes with or without Ac-H3K9, an active
transcriptional status could be attributed to target genes
(Fig. 4a). The number of FUS target genes without Ac-
H3K9 was very low (2 genes) which most likely explains
the lack of significant change in expression levels be-
tween FUS target genes without Ac-H3K9 relative to the
FUS and Ac-H3K9 target genes (Fig. 4a). A control set
of 200 randomized selected probes representing the
microarray was less expressed than probe sets with FUS
and Ac-H3K9, as well as EWS and Ac-H3K9, further
supporting that FUS and EWS target genes are actively
transcribed (Fig. 4a). We performed GO analysis of the
above described probe set groups representing actively
transcribed genes with ChIP-seq peaks of FUS, EWS and
Ac-H3K9 (Additional file 8). We note that this GO ana-
lysis is not directly comparable with the ChIP-Enrich
analysis presented in Table 2 due to different grouping
and definition of input genes. Nevertheless, consistence
with the ChIP-Enrich analysis was evident (Additional
file 8). For EWS and Ac-H3K9 probe set group the most
significant GO Biological Process was translational
elongation and GO Molecular Function was RNA binding
(Additional file 8). For the FUS and Ac-H3K9 probe set
we note that there was significant enrichment for GO Cel-
lular Component gene sets representing cytosolic ribo-
some, ribosomal subunit, and cytosolic large ribosomal







































































































Fig. 2 Graphical illustrations of representative ChIP-seq results. ChIP-seq sequence reads for input, FUS, EWS, Ac-H3K9 and RNAPII were aligned to
representative genes by Integrative Genomics Viewer 2.0. The number of sequence reads is presented on the y-axis within each figure. Transcripts from
the UCSC hg19 genomic database are shown in the bottom section of each figure. a ChIP-seq reads aligned to the neighboring ACPT and C19orf48
genes. b ChIP-seq reads aligned to the overlapping RCC1 and SNHG3 genes with additional inclusion of SNORA73A and SNORA73B genes. We note the
presence of major FUS and EWS peaks corresponding to the position of the annotated poly(A)-signal of SNHG3 as well as minor FUS and EWS peaks
4 kb further 3’ end positioned. c ChIP-seq reads aligned to the HNRNPK gene with additional inclusion of miR-7-1. Dashed lines separate the paired
input, ac-H3K9, FUS and EWS ChIP seq dataset from the paired input and RNAPII ChIP-seq dataset. Red arrows show positions of primers used for qPCR
based verification of ChIP results. Blue arrows under gene names show direction of transcription
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subunit, which were also detected by ChIP-Enrich. For the
probe set representing FUS, EWS, and Ac-H3K9 target
genes we observed enrichment of GO gene sets including
GO Molecular Function RNA binding and several
enriched gene sets related to ribonucleotide binding, as
well as the GO Biological Processes gene-expression and
translation (Additional file 8).
We further compared the actively transcribed gene
groups FUS and Ac-H3K9, EWS and Ac-H3K9, and
FUS, EWS, and Ac-H3K9, with microarray datasets
representing HEK-293 cells with siRNA mediated deple-
tion of FUS, EWS, or a combined FUS and EWS deple-
tion (Fig. 4b-d) [47]. Few of the transcribed EWS and
FUS target genes had altered transcription as a conse-
quence of EWS and FUS depletion, suggesting that the
binding of EWS and FUS to target genes is not essential
for the given transcriptional level (Fig. 4b-d).
Accumulation of RNAPII in the downstream region of
genes has been described to be relatively common [52].
Considering that FUS and EWS largely target genes that
are actively transcribed, we hypothesized that FUS and
EWS binding downstream the poly(A)-signal could be
associated with RNAPII accumulation. To investigate
this, we calculated the distance between RNAPII and
FUS or EWS peaks downstream the poly(A)-signal.
RNAPII genomic occupancy profile in HEK-293 cells
was obtained from ENCODE ChIP-seq data and FUS
and EWS ChIP-seq peaks located downstream the
poly(A)-signal is presented in Additional file 9. The ana-
lysis showed that FUS and EWS binding overlaps to
RNAPII binding, supporting that binding of FUS and
EWS downstream from the last exon is associated with
RNAPII accumulation (Fig. 5a). We next examined
whether FUS and EWS ChIP-seq peaks were intersecting
(defined as an overlap of at least one base pair) with
RNAPII ChIP-seq peaks. FUS and EWS ChIP-seq peaks
were categorized accordingly to their gene localization
as upstream, exon, intron, or downstream (see also
Table 1 and Fig. 1c). Note that one ChIP-seq peak can
belong to several categories. The intersection analyses
showed that in all FUS peak categories, most peaks
intersected with RNAPII binding (Fig. 5b). For FUS
peaks, the most prominent intersection with RNAPII
peaks was for peaks localized downstream (91 %)
(Fig. 5b). For EWS peaks, we observed a general lower
intersection with RNAPII peaks (Fig. 5b). Nevertheless,
we also observed for EWS peaks a prominent intersec-
tion between peaks localizing downstream and RNAPII
peaks (76 %) (Fig. 5b). Thus, we conclude that FUS and
EWS binding downstream the poly(A)-signal often asso-
ciates with RNAPII accumulation at the same position.
Extending the analyses to also examine for intersection
of FUS and EWS ChIP-seq peaks, we observed peak in-
tersections within all localization categories (Fig. 5c).
This is in alignment with the previous presented results
showing that FUS and EWS have a common group of
target genes (Fig. 3).
Functional analysis of exemplified FUS and EWS ChIP-seq
peaks
To investigate the functional implications of EWS and
FUS binding in representative genes, we performed de-
pletion of FUS, EWS or both, by transfecting HEK-293
cells with siRNA. Depletion efficiency was determined at
both mRNA and protein levels by qPCR and western
blot (Additional file 10). Firstly, we analyzed the gen-
omic region annotated with C19orf48 and ACPT genes.
For C19orf48, EWS, FUS, and RNAPII ChIP-seq peaks
were detected downstream the poly(A)-signal, as well as
having Ac-H3K9 and RNAPII ChIP-seq peaks at the
promoter region (Fig. 2a). We note that the ACPT gene,
 Comparison of FUS, EWS and Ac-H3K9 gene binding  











FUS EWS Ac-H3K9 
FUS 134 9 40 82 - 3 - - 
EWS 241 9 - 82 117 - 33 - 



















Fig. 3 Characterization of FUS and EWS target genes. a The 134,
241, and 15115 genes identified as potential targets for FUS, EWS
or Ac-H3K9, respectively, were in addition examined for also the
presence of peaks representing the two other ChIP-seq experiments.
b The percentage distribution of genes with either individual or
combined FUS, EWS, and Ac-H3K9 peaks. Percentages were
calculated from the numbers in (a)
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which directly overlaps with the FUS and EWS ChIP-seq
peaks, but not Ac-H3K9, was not expressed to a detect-
able level in HEK-293 cells, either with or without FUS
and EWS depletion, decreasing the likelihood that ACPT
represents a functional EWS and FUS target gene (data
not shown). To determine the eventual functional effects
of FUS and EWS, we next examined by RT-qPCR the
expression levels of C19orf48 isoforms, C19orf48 intron
retention, and amounts of the SNORD88 precursors
generated from C19orf48 intron sequences. The results
showed that FUS and EWS depletion had no direct
effect on the expression of the examined RNA species
using a significance threshold of 1.5 fold changes
(Additional file 11). We next analyzed the overlapping
RCC1 and SNHG3 gene complex (Fig. 2b). We note the
presence of major FUS and EWS enrichment corre-
sponding to the position of the annotated poly(A)-signal
of SNHG3, as well as minor FUS and EWS peaks
approximately 4 kb further downstream (Fig. 2b). The
RCC1-gene has different mRNA isoforms due to alterna-
tive transcription start sites and/or alternative splicing
(Fig. 2b). The RCC1 downstream transcription start site
is located after RCC1 exon 4 and displays overlapping
Ac-H3K9 and RNAPII enrichment peaks indicating ac-
tive transcription (Fig. 2b). The RCC1 upstream tran-
scription start site overlaps with the transcription start
site of SNHG3 gene, which is a non-coding gene. The
first two exons of the large forms of RCC1 and SNHG3
mRNAs are identical and two SNHG3 mRNA isoforms
can be produced from RCC1. This transcriptional start
site also contains overlapping enrichment peaks for Ac-
H3K9 and RNAPII (Fig. 2b). Additionally, two small nu-
cleolar RNA precursors, SNORA73A and SNORA73B,
are produced from the introns of RCC1 and SNHG3
genes (Fig. 2b). RT-qPCR was used to investigate if the
various RCC1, SNHG3 and SNORA73 RNA isoforms
generated from this genomic region were affected by de-
pletion of FUS and EWS. The only significant change
Fig. 4 FUS and EWS bind with preference actively transcribed genes. a Box plot of log 2 expression intensity of FUS, EWS, and combined FUS
and EWS target genes either without or with additional Ac-H3K9 enrichment. A random selection of 200 probe sets was used as microarray
control probe set. “a”, p-value < 0.05, for data sets compared against the randomly selected 200 probe sets; “*”, p–value < 0.05, when comparing
ChIP-seq signatures with and without H3K9; NS, non-significance. b-d Dot plots comparing microarray data for control and individual or coupled
FUS and EWS siRNA transfected cells with ChIP-seq signatures for FUS and Ac-H3K9 (n = 35) (b), EWS and Ac-H3K9 (n = 153) (c) or FUS and EWS
and Ac-H3K9 (n = 58) (d). The red line indicates the significant up-regulation boundary of log (siRNA-control) fold change = 0.8, and the green line
indicates the significant down-regulation boundary of log (siRNA-control) fold change = −0.8
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observed was reduction in RCC1 transcripts initiated
from the upstream transcription start site in FUS de-
pleted cells (Additional file 12). Finally, we analyzed the
HNRNPK gene, with FUS and EWS binding downstream
of the poly(A)-signal (Fig. 2c). Distinct HNRNPK mRNA
isoforms are produced by usage of two alternative first
exons, as well as alternative splice acceptor sites at the
last exon (Exon 16). Moreover, one of the microRNA
precursors of miR7-1 is generated from HNRNPK intron
15. The expression levels of HNRNPK transcripts were
not significantly changed by EWS and FUS depletion
(Additional file 13). To evaluate FUS and EWS effect on
alternative splicing involving exon 16, RT-PCR followed
by gel electrophoresis was performed. Two bands with
distinct sizes were observed for both coupled and indi-
vidual FUS and EWS depletions as well as for control,
reflecting the usage of proximal (P) and distal (D) ac-
ceptor sites (Fig 6a-c). FUS and EWS depletion caused a
significant increase of HNRNPK transcripts, which used
the distal exon 16 splice acceptor site (D) (Fig 6a-c and
Additional file 13).
Discussion
The coupling of transcription with RNA processing is
widely accepted and, in recent years, it has become more
evident that the functional importance of FUS and EWS
may reside in this interface. Several studies have addressed
the association of FUS and EWS with RNA. However, des-
pite early in vitro evidence for the DNA-binding proper-
ties of the FET-proteins [1, 12, 40, 41, 46, 47], few studies
identifying in situ target genes for FUS and EWS have
been conducted [24, 30, 53]. We here present a profile for
genomic binding of FUS and EWS by ChIP-seq in HEK-
293 cells. To our knowledge this is the first presentation
of EWS ChIP-seq data whereas one FUS ChIP-seq and
one FUS ChIP-chip dataset were previously published
[24, 30]. Our studies were conducted in HEK-293 cells
since other FUS and EWS RNomics and genomics
a b
c
Fig. 5 EWS and FUS binding downstream the poly(A)-signal overlap with RNAPII binding. a The distance in base pairs (bp) for the 41 FUS gene
localized and the 32 FUS downstream localized ChIP-seq peaks (yellow), as well as for the 103 EWS gene localized and the 62 EWS downstream
localized ChIP-seq peaks (green), to RNAPII binding (26,323 ChIP-seq peaks from ENCODE Project Consortium). Distances were plotted as histograms,
where x = 0 indicate the center of RNAPII binding. The y-axis show the number of FUS and EWS ChIP-seq peaks in each bar. b Presentation of the
percentage of FUS (grey) and EWS (white) ChIP-seq peaks, both for the total number of gene localized peaks, as well as peaks belonging to different
categories for gene localization, intersecting at least one base with RNAPII peaks. c Presentation of the percentage of FUS and EWS ChIP-seq peaks,
both for the total number of gene localized peaks, as well as peaks belonging to different categories for gene localization, that intersect (at least one
base). At the right side is shown the coloring code for the intersection percentages. The percentage of FUS, EWS, and RNAPII intersection with a
randomized generated peak set was < 1.8 % based on 1 x 105 simulations of the randomized peaks having the same length and chromosome
distribution as the RNAPII ChIP-seq peaks yielding a significance level of p < 1 x 10−5
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studies, including genome-wide RNA binding analysis
and FUS ChIP-seq analysis, have used the HEK-293
genetic background to dissect the regulatory functions.
Thereby, cross-experimental comparative analyses are
possible by minimizing potential interference from cell
line genetic differences and cell type specific gene ex-
pression profiles. Nevertheless, we acknowledge that
use of the single HEK-293 cell line model has limita-
tions in terms of delineating the general biological im-
plications of the identified FUS and EWS gene binding
profiles. It will be informative to extend FUS and EWS
ChIP-seq profiling to other cell models to study the
protein functions in more details and in relation to spe-
cific diseases involving FUS and EWS deregulation,
such as cancer and neurodegenerative disorders.
We identified a small number of significant peaks for
FUS (52 peaks) and EWS (133 peaks). Of these peaks, 41
for FUS and 103 for EWS were located within or in close
proximity (distance of 10 kb) of annotated genes. Given
that one peak at a given genomic position often can be
assigned to more than one annotated gene, 134 and 241
genes were identified as potential targets for FUS and
EWS, respectively. Interestingly, 91 genes were common
in situ targets for FUS and EWS. Moreover, our peak
intersection analysis showed that FUS and EWS ChIP-
seq peaks often overlap, which altogether supports a func-
tional cooperation or redundancy of these proteins. This
observation correlates with previous descriptions of FUS
and EWS being together in protein complexes [13, 54].
The hereby identified binding of FUS and EWS to genes
in HEK-293 cells could be directly mediated through mul-
tiple nucleic acid interaction domains in EWS and FUS,
or indirect as cross linking in the ChIP protocol
strengthens protein-protein and tripartite protein-RNA-
DNA interactions. In our study 16 % of FUS and 20 % of
EWS enrichment peaks were in the upstream gene region
including the promoter. FUS and EWS were reported to
both enhance and inhibit transcription, being a common
characteristic of these studies the binding of FUS and
EWS mainly at the promoter region [30, 43–45, 55, 56].
Additionally, genome-wide RNA cross-linking and IP
(RNA-CLIP) analysis has shown that FUS interacts with
antisense RNA originating from promoter regions [44].
This FUS-RNA interaction mediates transcriptional down
regulation from the coding strand, indicating a function of
FUS in transcription in a position-dependent manner [44].
Schwarts et al. showed that FUS binds the C-terminal do-
main (CTD) of RNAPII, preventing inappropriate CTD
Ser-2 hyperphosphorylation at thousands of human genes
[30]. FUS depletion caused RNAPII accumulation at the
transcription start site and a shift in the corresponding
mRNA expression profile towards usage of early poly(A)-
signals [30]. FUS ChIP-seq analyses in HEK-293 cells by
Schwarts et al. showed binding of FUS to the transcrip-
tional start site (TSS) in 68 % of transcribed genes, con-
comitant with RNAPII presence [30]. This contrasts with
our ChIP-seq data, where promoter and 5’ gene region
binding of FUS only constitutes a minor proportion of the
FUS in situ targets. We here also note that a FUS ChIP-
chip experiment by Tan et al. identified direct FUS inter-
action to promoter sequences in HeLa cells [24]. Whereas
Tan et al. data were not straightforward comparable
with our results due to different sample genetics and
ChIP methodology, a dataset comparison with FUS
ChIP-seq data from Schwarts et al. was more straight-
forward [24, 30]. The ChIP-seq experiment by Schwarts et
al. was performed in HEK-293 T/17 cells and our study in
the parental HEK-293 cell line. In ChIP-seq data analysis
we have compared input DNA sequences versus FUS
ChIP DNA sequences whereas Schwarts et al. compared




























































Fig. 6 FUS and EWS influence HNRNPK splice site selection. a Graphical
illustration of HNRNPK alternative splice acceptor site selection in exon
16. P, proximal splice site; D, distal splice site. On top are indicated
the coding region in gray and positions of translational stop (*) and
Poly(A)-signal (pA). b RT-PCR and gel electrophoresis of siEWS, siFUS,
siEWS and siFUS, and siControl depleted HEK-293 cells. This image is
representative of 3 independent experiments. M, 100 bp DNA ladder.
–RT, negative control of PCR mix without template cDNA. c Ratio of D
(distal) to P (proximal) splice acceptor site usage in siRNA transfected
cells. The ratio was calculated from relative band intensity values by
GelQuant software. The ratio for siCon was given the value 1 and the
ratios from siRNA-depleted samples were calculated accordingly.
Experiments were performed in biological triplicates. Data presented
as mean + SEM
Luo et al. BMC Genomics  (2015) 16:929 Page 10 of 17
pre-transfected with a scrambled siRNA control or siRNA
against FUS with the latter ChIP-seq only resulted in rela-
tive few sequence reads which could be mapped to hg19
(Additional file 14 and [30]). Secondly, Schwarts et al.
used the peak-calling software FindPeaks, whereas we
used MACS, with only MACS also using input DNA se-
quence data for peak estimation [57–59]. We reanalyzed
our and Schwarts et al. FUS ChIP-seq data with the Find-
Peaks and MACS peak calling programs. The p-value dis-
tribution for called peaks was similar between the two
datasets using MACS, whereas when using FindPeaks a
high proportion of the peaks called from Schwarts et al.
data clustered with high p-value (Additional file 15). The
distribution of MACS and FindPeaks called peaks over a
model gene was next analyzed using a serial decrease in
p-value cut-off levels. Using MACS peak calling, FUS
ChIP-seq peaks corresponding to promoter regions were
identified in our data, but not in numerical alignment with
Schwarts et al., which described preferential promoter as-
sociation to thousands of genes (Additional file 16). More-
over, MACS identified in both datasets a small number of
FUS ChIP-seq peaks downstream the poly(A)-signal
(Additional file 16). Using FindPeaks peak calling, FUS
ChIP-seq peaks corresponding to promoter association to
thousands of genes were identified only in Schwarts et al.
data, and preferentially with high p-values (Additional file
17). Moreover, using FindPeaks identified in our and
Schwarts et al. datasets a small number of FUS ChIP-
seq peaks downstream the poly(A)-signal (Additional
file 17). We conclude that overall discrepancies in ob-
tained results seem to be a combination of the DNA
co-immunoprecipitated under the given ChIP experi-
mental conditions, criteria used for peak calling, and
that the small number of downstream the poly(A)-sig-
nal peaks do not appear evident in the Schwarts et al.
study given the much larger FUS enrichment at pro-
moter regions. However, we find it important that the
identification of FUS and EWS binding downstream the
poly(A)-signal of a small subset of transcribed target
genes irrespectively of peak calling methods and sequence
datasets, indicates an overseen putative regulatory mech-
anism for gene targeting of FUS and EWS with potential
implications for regulation at the RNA level.
RNA processing factors can be recruited to transcribed
genes in multiple, not mutually exclusive, ways: i) by
binding to the DNA template either directly or through
recruiting factors, ii) by binding to processing signals
present in the nascent RNA and iii) by binding to de-
fined regions of the RNAPII elongating complex i.e.
CTD [60]. In mammals, RNAPII transcriptional termin-
ation can occur anywhere from a few bases to several kb
downstream from the poly(A)-signal [61]. Previous stud-
ies have revealed a general higher average RNAPII dens-
ity downstream from the poly(A)-signal compared to the
transcribed region [62, 63]. However, a subsequent study
proposed that these observations were biased, consider-
ing that most active genes have RNAPII evenly distrib-
uted before and after the poly(A)-signal, but that a
subset of actively transcribed genes (7 % to 14 %)
contained RNAPII enrichment downstream the poly(A)-
signal [52]. Association of 3’-end processing factors,
capping factors, Spt5, and Ser-2 hyper-phosphorylated
paused RNAPII was identified approximately 0.5-1.5 kb
downstream of the poly(A)-signal [60]. The CDK9 kinase
component of P-TEFb, which mediates RNAPII CTD
Ser-2 phosphorylation, is also present downstream of the
poly(A)-signal and this is being coupled with correct as-
sembly of the spliceosome [64]. Thus, RNAPII pausing
downstream of the poly(A)-signal, transcription termin-
ation and pre-mRNA processing seems to be highly in-
terconnected. A link to transcriptional re-initiation is
also opened [65]. GO analysis showed that genes with
and without downstream RNAPII enrichment are im-
plicated in different cellular functions [52]. It has been
shown that FUS and EWS interact with different spli-
ceosome components but also with RNAPII and TFIID
[1, 28, 66, 67]. In this line, EWS is shown to function as
a co-transcriptional regulator of alternative splicing
which can bind alternatively spliced exons at both the
chromatin template level and in the nucleoplasm [68].
FUS RNA-CLIP analyses showed widespread cross-
linking along the whole length of associated pre-RNAs,
suggesting that FUS associates with target RNAs until
splicing is completed [44, 69–71]. So far, simple RNA
binding motifs which could explain RNA-binding pat-
terns of EWS and FUS have not been identified, but a
preference for GU-rich motifs and short-stem loops
was proposed to facilitate binding [25]. The hereby de-
scribed binding of FUS and EWS downstream the
poly(A)-signal of actively transcribed genes often over-
laps RNAPII binding, and this could be mechanistically
linked with the gene recruitment process of FUS and
EWS. Comparative analysis of the identified FUS and
EWS target genes with expression data showed that tar-
get genes are mostly transcribed, but that neither FUS
nor EWS have in general major impact on basal tran-
scriptional activity. This is in alignment with other
studies pointing that, due to the discrepancy in the
number of identified FUS RNA targets and the number
of genes differentially expressed after alterations in the
FUS expression level, basal transcriptional regulation
seems to not be the main function of FUS [30, 70, 71].
Numerous studies have identified RNA targets for FUS
and EWS and characterized their regulatory impact.
RNA interactions have been extensively analyzed, par-
ticular after the identification of FUS mutations associ-
ated with ALS [26, 30, 44, 69–71]. A comparison of
RNA-CLIP identified RNA targets for FUS and EWS
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[26] and the genes hereby identified by ChIP-seq, showed
that 37 out of 134, and 68 out of 241 genes for FUS and
EWS, respectively, were overlapping (Additional file 18).
Note that FUS and EWS target genes characterized in
terms of expression in this report were also identified by
RNA-CLIP in Hoell et al. [26]. While addressing the regu-
latory function of FUS and EWS in this study, we were
unable to identify significant effects for C19orf48. For the
RCC1 gene, FUS and EWS seem to regulate the relative
levels of RCC1 transcript isoforms. One possible mechan-
ism could be that FUS and EWS binding in the SNHG3
gene, which is intragenic to RCC1, enhance the transcrip-
tion initiated from the upstream RCC1 promoter. Another
possibility could be that binding of FUS and EWS is as-
sociated with RNAPII pausing, which in turn could
modulate the subsequent splicing pattern of RCC1
mRNA. A similar mechanism is found regulating the al-
ternative splicing of CD45 mRNA mediated by the
DNA-binding protein CCCTC-binding factor [72]. In
addition, transcriptional pausing at terminal exons was
described as a general phenomenon linking chromatin
structure to RNA metabolism [73]. For the HNRNPK
gene, we observed a FUS and EWS function on alterna-
tive splice site selection at the last exon. In accordance,
FUS was also previously identified as a splicing regula-
tor of HNRNPK [25, 69, 71]. We note that depletion of
FUS and EWS results in up-regulation of the third
FET-protein, TAF15, and this indirectly could also par-
ticipate in the regulation (data not shown). During the
finalization of this manuscript it was described that
position-specific binding of FUS to nascent RNA regu-
lates mRNA length through alternative poly(A)-signal
usage [31]. FUS was shown to stall RNAPII and prema-
turely terminate transcription when FUS RNA binding
was downstream the poly(A)-signal [31]. We note that this
scenario could be in alignment with our observations of
FUS and EWS binding downstream the poly(A)-signal in
conjugation with RNAPII accumulation, and that FUS and
EWS could be involved in the functional regulation of 3’
end processing related events of such target genes. It is
clear that EWS and FUS regulate alternative RNA pro-
cessing of genes involved in neurodevelopmental and
neurodegenerative processes [25, 31, 44, 70]. FUS also
contributes to the biogenesis of a specific subset of
miRNAs, including species relevant for neuronal func-
tion, differentiation and synaptogenesis [53]. FUS RNA
CLIP-tag distributions are similar in mouse and human
neurons, indicating conserved functions for these
genes, and target mRNA GO terms implicated FUS in
the regulation of vital genes for neuronal maintenance,
development and function [31, 71]. GO analysis of FUS
and EWS mRNA targets revealed enrichment in bio-
logical processes of DNA repair and spliceosome as-
sembly [26, 74, 75], and preferential binding of FUS
with pre-mRNAs encoding RBPs was associated with a
regulatory function of FUS in alternative splicing of
RBP encoding genes in neurons [71]. Thus, FUS seems
to participate in a cross-regulatory network with other
RBPs, further suggesting that perturbations of FUS in
ALS and FTLD may result in both direct and indirect
transcriptome changes through the effect of FUS on
other RBPs [71]. Our results are in line with the above
mentioned studies, as GO profiles of EWS and FUS target
genes showed enrichment in signaling networks related to
ribosomal functions, RNA processing, and translation.
This further highlight the putative functions of FUS and
EWS in regulating genes encoding proteins associated
with the RNA regulome and that deregulation of particu-
lar components of this program may be an important fac-
tor in cancer and neurological diseases.
Conclusions
The presented results show that FUS and EWS associate
with a subset of transcribed genes, often downstream the
poly(A)-signal, and that the identified target genes are
functionally enriched for encoding proteins with role in
RNA regulatory mechanisms. The presented results yield
mechanistic insight into possible recruitment mechanisms
of FUS and EWS to target genes for regulation of cellular
pathways at the RNA level, and have identified novel FUS




HEK-293 cells were grown in Dulbecco’s Modified Eagle
Medium (DMEM) with 10 % Fetal Bovine Serum, strepto-
mycin (2.0 g/l), penicillin (1.2 g/l) and glutamine (0.3 g/l)
(complete DMEM). HEK-293 cells were obtained from
the American Type Culture Collection (CRL-1573). Cells
were grown at 37 °C and 5 % CO2. None of the experi-
ments were using primary human material and cells and
all experiments were performed in accordance with the
declaration of Helsinki and under conditions approved by
Danish institutional and governmental legislation.
Chromatin Immunoprecipitation (ChIP)
The protocol used was merged from [76], [55] and Mag-
nify chromatin immunoprecipitation system (Invitro-
gen). Briefly, HEK-293 cells (1x107per 10 cm petri dish)
were cross-linked directly on plates by adding 37 % for-
maldehyde to the media in a 1.4 % final concentration
for 15 min at room temperature. Cross-linking was
stopped by adding glycine (final concentration 125 mM)
followed by incubation for 5 min, at room temperature.
Cells were scraped off in 500 μl of ice-cold 2x Phosphate
Buffered Saline (PBS) and transferred to eppendorf-
tubes and placed on ice. Cells were centrifuged at
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2,000 g for 5 min, at 4 °C, and washed twice with ice-
cold PBS. Cells were lysed in 500 μl of ice-cold immu-
noprecipitation (IP)-Buffer (150 mM NaCl, 50 mM
Tris–HCl (pH 7.5), 5 mM EDTA, 1 % Triton X-100,
0.5 % NP40) supplemented with Complete Mini prote-
ase inhibitor cocktail (Roche), hereafter referred to as
supplemented IP-Buffer. Samples were centrifuged at
12,000 g for 1 min, at 4 °C, and washed once in ice-
cold supplemented IP-Buffer. 500 μl of ice-cold supple-
mented IP-Buffer were added to the pelleted nuclei and
sample re-suspended. Chromatin was fragmented by
sonication using a Bioruptor (Diagnode) at high effect
(80 cycles, 30s on plus 30s off ) to generate fragments
of 150–300 bp. Fragment lengths were examined by
agarose gel electrophoresis. Samples were centrifuged
at 12,000 g for 10 min, at 4 °C. Supernatants were
transferred to fresh ice-cold tubes and stored at −80 °C.
For each ChIP experiment, material corresponding to
5x106 starting cells was used. Samples were diluted with
an equal volume of D-Buffer (150 mM NaCl, 50 mM
Tris–HCl (pH 7.5), 5 mM EDTA, 1 % Triton X-100).
5 μg of antibody (FUS sc-47711 Santa Cruz and EWS
sc-48404 Santa Cruz) or 2 μg antibody for acetylated
histone protein (ac-H3K9 ab4441-50 Abcam) were used
for each ChIP. Samples were incubated in an ultrasonic
water bath for 25 min, at 4 °C, and afterwards centri-
fuged at 12,000 g for 10 min, at 4 °C. 20 μl magnetic
AG-beads (Invitrogen) were used for each ChIP. Beads
were washed 3 times in 1 ml of supplemented IP-Buffer
before use. After the final wash, beads were suspended
in 40 μl of supplemented IP-Buffer and mixed with 90 %
of the chromatin supernatant described above. The mix
was incubated in rotation overnight, at 4 °C. Beads were
washed twice with 200 μl of ice-cold supplemented IP-
Buffer and three times with 200 μl ice-cold D-Buffer
supplemented with protease inhibitors. Cross-linking
was reversed by adding Reverse X-link Buffer and Prote-
ase K (Invitrogen) and incubating in water bath for
20 min, at 55 °C. The remaining 10 % of the reversed
cross-linking chromatin supernatant was used as input.
Supernatants were transferred to fresh tubes and incu-
bated at 95 °C to inactivate Protease K. DNA was purified
using DNA Purification Buffer plus DNA purification
magnetic beads, as recommended (Invitrogen). DNA was
stored at −20 °C.
ChIP-sequencing (ChIP-seq) and bioinformatics
DNA from single FUS, EWS, and Ac-H3K9 ChIP ex-
periment, as well as the corresponding input, was se-
quenced using the Illumina Hiseq 2000 platform at BGI
in Shenzhen, China. Library preparation, cluster gener-
ation and sequencing by synthesis were performed ac-
cording to manufacturer’s protocol. All raw reads were
aligned using Burrows-Wheeler Aligner (BWA version
0.5.8c (r1536) [48]) to the human reference genome
(hg19). Aligned reads were processed by Model-based
Analysis of ChIP-seq (MACS) 1.4.0rc2 [49] for peak
calling. Significant peaks were defined using the criteria
of a threshold of minimally 9 reads and p-value less
than 10−8 as suggested previously [50]. Input ChIP
DNA was used as negative control. ChIP experiments
were independently repeated and ChIP-seq called peaks
verified by qPCR.
RNAPII binding sites in HEK293 cells were identified
using ChIP-seq data from the ENCODE Project Consor-
tium (PMID: 22955616) [77]. ChIP-seq fastq files were
downloaded from http://genome.ucsc.edu/ENCODE/
downloads.html. Sequenced reads were mapped to hg19
with Bowtie (PMID: 19261174) allowing one mismatch.
Peak calling was performed using the Model-based
Analysis of ChIP-seq v1.4 (MACS) (PMID: 18798982)
identifying 26,323 peaks.
FUS and EWS depletion
siRNAs against the FUS and the EWS mRNAs were
used as a mix of two siRNAs for each protein (MWG,
Germany). siRNA sequences for EWS: 5’-CGAGGAGG
AAGGAGAGAAA-3’ and 5’-GAGTAGCTATGGT-
CAACAA-3’, and for FUS: 5’-ACAGCCCATGATT
AATTTGTA-3’ and 5’-GGGAGAAGGCCAAATGATA-
3’. Control siRNA is a non-specific siRNA with the se-
quence 5’-CUGAUGCAGGUAAUCGCGU-3’. 24 h be-
fore transfections HEK-293 cells were reseeded in fresh
media at 40 % confluence. 2x105 HEK-293-cells were
seeded in a 6-well plate and transfected in suspension
using Dharmafect-1 (Dharmacon) and 100 nM of final
siRNA concentration. Cells were incubated for 48 h be-
fore switching to fresh complete DMEM and transfected
again using TransIT-siQUEST (Mirus) and 100 nM of
final siRNA concentration. Cells were harvested after an-
other 48 h. Transfections were performed in duplicates
and pooled upon harvest.
Western blotting
For ChIP control experiments samples were processed
according to the ChIP protocol until the reverse cross-
linking step. Beads and input samples were given 2.5x
Loading Buffer and Reducing Agent (Fermentas),
followed by heating to 95 °C for 5 min. For siRNA me-
diated depletion experiments samples were processed
essential as described previously [17]. Antibodies used
were FUS (FUS sc-47711 Santa Cruz) and EWS (EWS
sc-48404 Santa Cruz) in 1:2000 dilutions and 4 F4 pri-
mary antibody as a loading control in 1:10,000 dilu-
tion. All procedures were essential as previously
described [17].
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RNA extraction and cDNA synthesis
RNA was extracted using TRI-Reagent (Sigma) accord-
ing to the manufacturer’s protocol. cDNA was synthe-
sized from 1 μg of total RNA in 20 μl reactions using
iScript™ cDNA synthesis Kit (Biorad). After synthesis,
the cDNA was diluted five times with double distilled
water and stored at −20 °C.
Quantitative PCR (qPCR)
FUS and EWS peak enrichment validation was per-
formed by qPCR analysis. Briefly, 1 μl ChIP-DNA was
used as template with 3 pmol of each primer. Primer se-
quences are shown in Additional file 19. qPCR analysis
was performed on a Lightcycler 480 (Roche). All reac-
tions were done in triplicates in a total volume of 10 μl
each using Lightcycler 480 SYBR Green I Master
(Roche), according to manufacturer’s instructions. Cycle
conditions: 95 °C 10 s, 58 °C 20 s, 72 °C 30 s, 45 repeats.
Reaction specificity was confirmed by melting curve ana-
lysis and gel electrophoresis. Primer efficiency (above
95 %) was measured by dilution standard curves. The
DNA amount was quantified as percent of the amount
measured in the input sample using the X0-method [78].
For negative control, primers were designed targeting
the promoter region of the non-transcribed IFRG28 gene
[79]. For RNA quantifications by RT-qPCR, conditions
were similar to above-described. Specificity and primer
efficiency were evaluated as described above. The DNA
amount was normalized to the expression of the house-
keeping genes GAPDH (Glyceraldehyde 3-phosphate de-
hydrogenase) and TBP and the relative cDNA levels of
each individual gene quantified relative to the amount
detected in the control cells treated with the unspecific
siRNA using the X0-method [78]. EWS, FUS, EWS and
FUS siRNA-depleted and control HEK-293 cells were
tested for variations of the alternative splicing pattern at
the last exon of HNRNPK mRNA. A primer set was de-
signed which amplified a fragment of 491 bp corre-
sponding to the proximal splice acceptor site usage and
a fragment of 431 bp corresponding to the distal splice
acceptor site usage. PCR amplification was performed
with a 2720 Thermal Cycler (Applied Biosystems). Amp-
lification was done within the exponential phase (28–30
cycles) to ensure that the PCR reaction was in the linear
amplification range. PCR products were run on a 2 %
agarose TAE gel with a 100 bp DNA ladder (Bio Labs,
Ipswich, Massachusetts) and relative band intensities
were quantified by GelQuant.NET software provided by
http://biochemlabsolutions.com. All qPCR experiments
were done in triplicates.
Availability of data and materials
Supporting data is included in Additional files 1, 2, 5, 6,
7, 8, 9, 14, 15, 16, 17, 18, and ChIP-seq and chip data
available at NCBI Bio projects accession PRJNA185008,
NCBI Gene Expression Omnibus (GEO) entry: GSE35578
and GEO entry: GSE73492.
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negative control for enrichment. A control ChIP experiment was also
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antibodies. Data represents three independent experiments and standard
deviation shown by error bars. A. C19orf48 and ACPT; B. RCC1 and SNHG3;
C. HNRNPK. (PDF 23 kb)
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(CH): the peak start and end in base pairs; Length: the peak length in
base pairs; Tags: the number of sequences included in the peak; p-value:
p-value on log2 scale; fold-change (fc): relative to input sample; FDR:
false discovery rate in percent; ENS ID: gene ID in the ensemble database;
gene location: location of the enrichment in the gene (upstream, downstream,
intron, exon); and T: number of known transcript variants produced
from the given gene. (DOCX 325 kb)
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of genes presented with FUS, EWS, FUS and EWS, and Ac-H3K9
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transcribed genes also presented with FUS and Ac-H3K9 (n = 35),
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Additional file 10: Consequences of siRNA mediated depletion
of FUS and EWS for gene expression. HEK-293 cells were double-
transfected with specific siRNAs for FUS, EWS and FUS plus EWS, and as
well as with a control siRNA (siControl). A. siRNA-depleted cells were
used for relative mRNA quantification of FUS and EWS by qPCR. FUS and
EWS expression was normalized to reference gene TBP. Experiments were
performed in triplicates. Data presented as mean + SEM. Similar qPCR
expression analyses showed a 1.5 to 2 fold increase in TAF15 mRNA by
EWS and FUS depletion (not shown). B. Protein quantification by western
blot of FUS and EWS from siRNA and control transfected cells. 4 F4
antibody recognizing HNRNP C1 + C2 was used as a loading control.
(PDF 276 kb)
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Additional file 11: Analysis of ChIP-seq FUS and EWS enrichment
peaks in the ACPT and C19orf48 gene complex. A. Graphic
distribution of ChIP-seq reads aligned to the ACPT and C19orf48 genes
from the input, FUS, EWS and Ac-H3K9 ChIP-seq samples. The number of
reads is shown on the scale to the left of each figure. The transcripts from
the genes in the UCSC hg19 genomic database are shown in the bottom.
The arrows beneath peaks illustrate location of the several qPCR amplicons
used. The arrows above the transcripts illustrate location of RT-qPCR
amplicons. Numbers above arrows denotes target exon numbers. B-C.
FUS and EWS effect in ACPT and C19orf48 expression. The expression
levels of C19orf48 transcripts were determined by qPCR from HEK-293
cells transfected with siRNA for FUS and EWS or control siRNA. Three
independent experiments were performed and error bars indicate
standard deviation. In B. simultaneous depletion of FUS and EWS was
performed, whereas in C. FUS and EWS were individually depleted.
(PDF 483 kb)
Additional file 12: Analysis of ChIP-seq FUS and EWS enrichment
peaks in the RCC1 and SNHG3 gene complex, including SNORA73A
and SNORA73B genes. A. Graphic distribution of ChIP-seq reads aligned
to the RCC1 and SNHG3 genes from the input, FUS, EWS and Ac-H3K9
ChIP-seq samples. The number of reads is shown on the scale to the left
of each figure. The transcripts from the genes in the UCSC hg19 genomic
database are shown in the bottom. The arrows beneath peaks illustrate
location of the several qPCR amplicons used. The arrows above the transcripts
illustrate location of RT-qPCR amplicons. Numbers above arrows denotes
target exon numbers. B-C. FUS and EWS effect for RCC1, SNHG3 and snoRNA
expression. The expression levels were determined by qPCR from HEK-
293 cells transfected with siRNA for FUS and EWS or control siRNA. Three
independent experiments were performed and error bars indicate standard
deviation. In B., simultaneous depletion of FUS and EWS was performed,
whereas in C. FUS and EWS were individually depleted. (PDF 552 kb)
Additional file 13: FUS and EWS regulate RNA processing in the
3’-end of HNRNPK. A. Graphic distribution of ChIP-seq reads aligned to
HNRNPK. The number of reads is shown on the scale to the left of each
figure. The transcripts from the genes in the UCSC hg19 genomic database
are shown in the bottom. The arrows beneath peaks illustrate location of
qPCR amplicons. The arrows above the transcripts illustrate location of
RT-qPCR amplicons. Numbers above arrows denote target exon numbers.
B-C. The expression levels were determined by qPCR from HEK-293 cells
transfected with siRNA for FUS and EWS or control siRNA. In B, simultaneous
depletion of FUS and EWS was performed, whereas in C FUS and EWS were
individually depleted. All values were normalized to reference gene TBP.
All experiments were performed in triplicates. *P < 0.05; **P < 0.01. Data
presented as mean + SEM. D-E. FUS and EWS involvement in the production
of miR7-1 from HNRNPK intron 15. By RT-qPCR the relative amounts of mature
miR7, premiR7-1 and pri-miR7-1 were determined by RT-qPCR from HEK-293
cells transfected with siRNA for FUS and EWS or control siRNA. In D.,
simultaneous depletion of FUS and EWS was performed, whereas in E.
FUS and EWS were individually depleted Values were normalized to
reference gene RNU48. **P< 0.01, ***P< 0.001, ****P< 0.0001. All experiments
were performed in triplicates. Data presented as mean + SEM. (PDF 549 kb)
Additional file 14: Comparative analysis and alignment to the
human genome (UCSC hg19) of raw FUS ChIP-seq reads from this
study and recalculated from the few data files presented in the
study by Schwartz et al. [30]. (DOCX 16 kb)
Additional file 15: Comparative distribution of p-values for ChIP-
seq peaks called by FindPeaks and MACS of data from this study
and the study by Schwarts et al. [30]. A. Distribution of p-values for
ChIP-seq peaks called by FindPeaks (F). Most of the ChIP-seq peaks from
the hereby presented FUS ChIP-seq data (unFUS_JB) have a low p-value.
Most of the ChIP-seq peaks from Schwartz’s et al. (unFUS_ref) have a high
P-value. B. Distribution of p-values for ChIP-seq peaks called by MACS. A
lower number of ChIP-seq peaks were identified compared to with usage
of FindPeaks and the p-value distribution is more comparable between
the two datasets. (DOCX 106 kb)
Additional file 16: Comparison of the distribution of MACS called
ChIP-seq peaks across a gene model using data from this study or
the study by Schwarts et al. [30]. A. ChIP-seq data from this study for
FUS (unFUS-JB) and B. ChIP-seq data from Schwarts et al. for FUS from
cells not pretreated with FUS siRNA (unFUS-ref). Cut-off levels for P-values
are indicated to the left for each figure panel. Data were plotted using
gene modelling with number of hits, which represents the number of
annotated UCSC transcripts corresponding to the position of a given
ChIP-seq peak, shown at the y-axis. The gene model presented on the
x-axis is based on the following features: position 1 – 100: UP, 10 kb
upstream region of the transcription start site of coding genes; NCUp,
10 kb upstream region of the transcription start site of noncoding genes;
Position 100–200: U5Exon, 5’ untranslated exon region; U5Intron, 5’ intron
region upstream of the translation start site; Position 200–300: Exon,
Coding region of the exon sequences; Intron, Intron region between the
translation start site and stop site; NCExon, Exon region of noncoding
genes; NCIntron, Intron region of noncoding genes; Position 300–400:
U3Exon, 3’ untranslated exon region; U3Intron, 3’ intron region downstream
of the translation stop site; Position 400–500: Down, 10 kb downstream
region of the poly(A)-signal of coding genes; UCDown, 10 kb downstream
region of the transcription poly(A) of noncoding genes. The features were
subdivided in smaller segments for precision mapping. C. MACS peak
output from Schwarts et al. data of the exemplified ACPT and C19ORF48,
SNHG3 and RCC1 and HNRNPK genes. (DOCX 842 kb)
Additional file 17: Comparison of the distribution of FindPeaks
called ChIP-seq peaks across a model gene using data from this
study or the study by Schwarts et al. [30]. For A. and B. legend
details see Additional file 16. (DOCX 693 kb)
Additional file 18: Genes co-identified in the hereby presented
ChIP-seq data and RNA-CLIP from Hoell et al. [26]. (DOCX 37 kb)
Additional file 19: List of primer sequences for PCR. (DOCX 20 kb)
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